DCM
BNTX icon

Discovery Capital Management’s BioNTech BNTX Stock Holding History

Discovery Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,700
Closed -$3.65M – 81
2024
Q3 		$3.65M Hold
30,700
– – 0.44% 41
2024
Q2 		$2.47M Buy
+30,700
New +$2.81M 0.32% 39
2021
Q4 		– Sell
-13,700
Closed -$3.74M – 71
2021
Q3 		$3.74M Buy
+13,700
New +$4.35M 0.28% 47

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Discovery Capital Management's BNTX Position: Q4 2024 in Review

Discovery Capital Management sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 30,700 shares — an estimated $3.65M sold.

Discovery Capital Management first reported a position in BNTX in Q3 2021 and held it in 3 quarters. The position peaked at $3.74M in Q3 2021. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Discovery Capital Management reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Discovery Capital Management sold 30,700 BioNTech shares in Q4 2024, an estimated $3.65M.
  • Discovery Capital Management first reported a position in BioNTech in Q3 2021 and held it in 3 quarters.
  • Discovery Capital Management's BioNTech position peaked at $3.74M in Q3 2021.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Discovery Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.